Showing results (171-180 of 193) with videos related to
Sort By:
Pageof 20
European Journal of Nuclear Medicine and Molecular Imaging|February 28, 2009
Bone marrow dosimetry in peptide receptor radionuclide therapy with [177Lu-DOTA(0),Tyr(3)]octreotateFlavio Forrer, Eric P Krenning, Peter P Kooij, et al.Journal of Neuro-Oncology|March 26, 2021
Evaluation of Ac-Lys0(IRDye800CW)Tyr3-octreotate as a novel tracer for SSTR2-targeted molecular fluorescence guided surgery in meningiomaBianca M Dijkstra, Marion de Jong, Marcus C M Stroet, et al.European Journal of Nuclear Medicine and Molecular Imaging|March 7, 2009
Comparison of three radiolabelled peptide analogues for CCK-2 receptor scintigraphy in medullary thyroid carcinomaAlida C Fröberg, Marion de Jong, Berthold A Nock, et al.Pharmaceutics|January 21, 2022
The Effect of VPA Treatment on Radiolabeled DOTATATE Uptake: Differences Observed In Vitro and In VivoMaria J Klomp, Leo J Hofland, Lilian van den Brink, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 24, 2019
Imaging DNA Damage Repair In Vivo After 177Lu-DOTATATE TherapyEdward O'Neill, Veerle Kersemans, P Danny Allen, et al.European Journal of Nuclear Medicine and Molecular Imaging|April 5, 2011
Comparative biodistribution of 12 ¹¹¹In-labelled gastrin/CCK2 receptor-targeting peptidesPeter Laverman, Lieke Joosten, Annemarie Eek, et al.European Journal of Nuclear Medicine and Molecular Imaging|October 23, 2020
Extensive preclinical evaluation of lutetium-177-labeled PSMA-specific tracers for prostate cancer radionuclide therapyEline A M Ruigrok, Nicole van Vliet, Simone U Dalm, et al.Theranostics|May 11, 2016
Towards Personalized Treatment of Prostate Cancer: PSMA I&T, a Promising Prostate-Specific Membrane Antigen-Targeted Theranostic AgentKristell L S Chatalic, Sandra Heskamp, Mark Konijnenberg, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 22, 2014
Preclinical comparison of Al18F- and 68Ga-labeled gastrin-releasing peptide receptor antagonists for PET imaging of prostate cancerKristell L S Chatalic, Gerben M Franssen, Wytske M van Weerden, et al.Cancers|February 11, 2023
In Vivo Efficacy Testing of Peptide Receptor Radionuclide Therapy Radiosensitization Using OlaparibDanny Feijtel, Thom G A Reuvers, Christine van Tuyll-van Serooskerken, et al.Pageof 20